{"domain":"connectbiopharma.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"Connect Biopharma - V2.0","summary":"Connect Biopharma is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammatory diseases. Their lead product candidate, rademikibart, is an antibody targeting IL-4Rα, showing promise in treating atopic dermatitis and asthma. The site details their publications, presentations, ongoing clinical trials, and pipeline, emphasizing their commitment to improving patient lives through advanced research and development.","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://connectbiopharma.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-27T13:00:32.335Z","agent_terms":null,"categories":["healthcare","science-research"],"capabilities":["mcp"],"inferred_tags":["biopharmaceutical","rademikibart","il-4ra antibody","atopic dermatitis","asthma","clinical trials"],"audience":"mixed","agent_uses":["read_docs","search_content"],"language":"en","platform_generated":false,"agent_summary":"Clinical-stage biopharma developing rademikibart, an IL-4Rα antibody for atopic dermatitis and asthma; site lists publications, presentations, trials and pipeli","llms_txt_cached":"https://agentwebmap.com/v1/domain/connectbiopharma.com/llms.txt","agentic":"interface","section_keys":["ai-agent-access","available-mcp-tools","callwixsiteapi","generatevisitortoken","getbusinessdetails","homepage-link","notes","readfulldocsarticle","readfulldocsmethodschema","searchinsite","searchsiteapidocs","what-visitors-can-do-via-ai-plus-mcp"],"section_partial":false,"section_indexed_at":"2026-10-26T09:41:23.635Z"}